Pediatric endocrinology industry updates

Updates you should know

Thursday, January 25, 2021

If your child has diabetes and uses a pump, CGM or is considering starting one, read this article for a preview of many developments in the technology space anticipated to come this year. Additionally, you can find a focused sneak peek of the Tandem t sport patch pump.

Omnipod 5 Closed Loop Insulin Pump

Thursday, November 19, 2020

Insulet, the makers of the Omnipod pump, recently announced that the pivotal trial of their Omnipod 5 Closed Loop insulin pump has completed. While those trial results are still being analyzed, and the pump is not yet available, results from some of the earlier clinical trials are starting to make the rounds at this year's annual diabetes meetings. Omnipod has released a brief presentation summarizing some of the results from their first in-home study of this new closed loop system.

Freestyle Libre 2.0

Thursday, August 13, 2020

Speaking about CGMs, exciting news from Abbott last month, as their Freestyle Libre 2.0 sensor was approved by the FDA. The newest generation Libre is approved down to age 4, and will bring optional high and low glucose alerts to the Libre ecosystem.  We hope to see these hit store shelves in the coming 1-2 months. Please don't hesitate to ask your care team about this at your child's next visit if this is of interest to you.

Delays expected in Dexcom G7, newer pumps

Thursday, June 25, 2020

The delay in execution of clinical trials worldwide due to COVID 19 has already led to companies starting to announce anticipated delays in availability of their upcoming product pipeline. Dexcom has announced an anticipated 6 month delay in their G7 CGM system. We anticipate proportional delays in Insulet's launch of their Horizon closed loop system as well.

InPen App updated

Thursday, April 16, 2020

The Inpen – the only available smartpen on the market, from Companion Medical, now supports Fiasp. The mobile app was updated on April 6 with a redesigned home-screen and logbook, bringing dose recommendations to the home screen and allowing users to view glucose, insulin and carbs on one integrated graph. It will even display your long-acting doses, if you record them! New therapy modes, which might make the device more attractive to our patients with type 2 diabetes, are also now available. For more information about smartpens, view our informational video.

CGMS approved by Texas Medicaid

Thursday, April 16, 2020

Our team is thrilled to announce that as of April 1, therapeutic CGM devices (those approved for non-adjunctive care, including the Dexcom G6 system) are now approved by Texas Medicaid plans. Many downstream details remain to be worked out, but if you are on a state Medicaid plan, please plan to talk to your care team at your next visit about what this means for your child in terms of home options for glucose monitoring.

Glucagon

Thursday, March 19, 2020

With so many developments regarding new formulations of glucagon products in the past few months, it can be hard to keep your arms around all the available options. See a summary of all the available options from our team.

Real‑time status updates from Dexcom

Thursday, February 20, 2020

Were you affected by the recent Dexcom service outages? Wish you could get live updates on the status of their service? Now you can! Launched this month, you can now see live, real‑time updates on the functionality of all of their services.

An in‑app messaging feature is coming soon, but in the meantime, bookmark the above link to stay in‑the‑know about any future Dexcom outages.

Control-IQ Availability

Thursday, January 16, 2020

Tandem’s Control-IQ Hybrid Closed Loop algorithm received FDA approval in late 2019 and a software upload is expected to be available any day now to users of the Tandem X2 pump.  Read for more details. 

FDA Approval for Control-IQ

Thursday, December 19, 2019

Late breaking, Tandem’s Control-IQ hybrid closed loop system earned FDA approval on December 13, with expected consumer availability by late January 2020!  Much more to come on this soon! Read BeyondType1's article for a quick update.

Accu-Chek® Guide Meter Advisory 

Monday, November 25, 2019

If you use Accu-Chek ® Guide blood glucose meters for monitoring, see an important advisory from Roche. 

Pediatric Diabetes Blood Glucose Logs 

Monday, November 25, 2019

If you still prefer good old-fashioned paper logs to track your child’s glucose values, you’ll want to check out our revised Blood Glucose Logs. We've updated our paper glucose logs, with your input, to better capture what families want, in English and Spanish, for Dallas and Plano. 

OmniPod receives ACE designation from FDA

Thursday, October 17, 2019

The Omnipod Dash system received approval as an "alternate controller enabled (ACE)" pump. This allows the pump to communicate with connected devices such as the Dexcom CGM system, clearing one of the hurdles for both the Horizon and Omnipod Loop systems in development. 

More on Glucagon

Friday, September 20, 2019

Last month it was nasal glucagon. This month, we have word that the first room-temperature, liquid-stable form of glucagon to treat hypoglycemic emergencies for children on insulin received FDA approval. We hope to see it available for patients within a couple months.  Both of these products offer their own unique advantages – if you think either might be right for your child with diabetes, speak to your diabetes care team at your next visit. 

Tandem Announcements 

Monday, August 26, 2019

Tandem Diabetes Care announced all feature updates to the t:slim X2 Insulin Pump will be offered for no cost through the end of 2020. Tandem also submitted their Control-IQ hybrid closed loop algorithm to the FDA. And the team at BeyondType1.org, shared coverage of the trial results.  

Omnipod DASH iOS Mobile Apps now available

Monday, August 26, 2019

The new Dash PDM system companion mobile apps - OmniPod Display and OmniPod VIEW - are now available for iOS users.  Learn more about some of the best features of these apps. 

Nasal Glucagon

Monday, August 26, 2019

The start of the school year is always a great time to check that vial of glucagon and make sure it has not expired. There have been some significant glucagon developments including FDA approval of a new form of the "rescue drug" designed for nasal administration. Learn more.

Medtronic 780G Clinical Trial Announced

Thursday, July 18, 2019

Last month, Medtronic announced the opening of enrollment for their in-home study of their Advanced Hybrid Closed Loop pump, termed the 780G. The 780G pump will introduce automated bolus dosing for the first time into the Medtronic algorithm. 

ADA 2019

Friday, June 21, 2019

The 79th Scientific Sessions of the American Diabetes Association (#ADA2019) just concluded in San Francisco, and there were a number of exciting announcements. 

Omnipod's new Insulin Management System

Friday, May 17, 2019

Big news for Omnipod users! Insulet, the company behind the tubeless, patch pump, announced wider US availability of their new DASH™ Insulin Management System in late April. Learn more.

Dexcom Clarity App Updated

Friday, May 17, 2019

The Clarity App was updated in April for both Android and iOS users, bringing several new features into production, including the ability to set “time-in-range” goals and to receive notifications for meeting those goals. If you are a Dexcom user and not familiar with the Clarity App, learn about this mobile-friendly way to view your CGM data both on your smart devices and on your computer screen. 

What's next for Dexcom?

Friday, May 17, 2019

Want a glimpse into the future? Dexcom announced a number of details about their future roadmap at their December 2018 investor's call. This one is full of technical details, but some of you may be interested in reading more about Dexcom’s partnership with TypeZero technologies, which they hope to leverage to bring advanced decision support to their product line in the near future. And we know you’ll like the picture on page 26!  

LibreLinkUp

Monday, April 22, 2019

Abbott announced earlier this month the U.S. release of their LibreLinkUp app, which brings "share-follow" functionality to the Freestyle Libre flash CGMS system. After a brief setup process, parents will now be informed of glucose tracing results, on their mobile device, any time your family member scans their Libre sensor.

Insulin Cost

Monday, April 22, 2019

If you or a loved one is affected by diabetes, you likely already know about the rising cost of insulin. Some powerful statements regarding cost were made at the  recent congressional hearings. 

Resources on how to save and advocate for lower costs: 

• American Diabetes Association
• Juvenile Diabetes Research Foundation
• Insulin Affordability Taskforce Guide 

"Hey Siri, what's my blood sugar?"

Thursday, March 21, 2019

Dexcom G6 mobile app users - have you upgraded to version 1.4.0? Released late February, the latest version brings a host of new functionality to the table. Read about all the new features of the latest version of the app (including an increase in the number of followers you are allowed) and, for Apple users, "Hey Siri" functionality now available through the Apple Shortcuts tool.

An update on the fludrocortisone shortage

Thursday, March 21, 2019

For our patients with adrenal insufficiency, on fludrocortisone, read about some important updates on the nationwide shortage of the medicine from the National Adrenal Diseases Foundation (NADF). If obtaining the drug has been a challenge at your local pharmacy, share this update with your pharmacist.

Freestyle Libre 14-day sensor approved for use 

Thursday, February 21, 2019

If you are a user of the Freestyle Libre 10-day flash (continuous) glucose sensor, you should know that the new sensors, approved for 14 days of wear, were recently approved for distribution in the U.S. The new sensors also introduce the ability to pair your sensor with certain iOS smartphones, allowing you to leave the receiver behind completely. Talk to your care team at your next visit if you're interested in this upgrade.